Showing results (121-130 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 16, 2020
Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experienceAnupama Suresh, Akannsha Ganju, Evan Morgan, et al.Investigational New Drugs|January 20, 2020
Pharmacokinetics of mitomycin-c lipidic prodrug entrapped in liposomes and clinical correlations in metastatic colorectal cancer patientsAlberto A Gabizon, Esther Tahover, Talia Golan, et al.Investigational New Drugs|February 27, 2020
Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcomaZhichao Tian, Huimin Liu, Fan Zhang, et al.Investigational New Drugs|November 3, 2020
Nab-paclitaxel-based regimens with docetaxel-based regimens as neoadjuvant treatment for early breast cancerYimeng Chen, Baoshi Bao, Yao Lv, et al.Investigational New Drugs|November 20, 2020
Arborinine, a potential LSD1 inhibitor, inhibits epithelial-mesenchymal transition of SGC-7901 cells and adriamycin-resistant gastric cancer SGC-7901/ADR cellsYafei Chu, Zheng Xiao, Nan Jing, et al.Investigational New Drugs|October 23, 2020
A retrospective comparative study of S-IROX and modified FOLFIRINOX for patients with advanced pancreatic cancer refractory to gemcitabine plus nab-paclitaxelKei Saito, Yousuke Nakai, Naminatsu Takahara, et al.Investigational New Drugs|October 24, 2020
Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinomaMasahide Fukudo, Gaku Tamaki, Makoto Azumi, et al.Investigational New Drugs|September 7, 2020
Correction to: Phase 1 dose-escalation study of a novel oral PI3K/mTOR dual inhibitor, LY3023414, in patients with cancerShunsuke Kondo, Masaomi Tajimi, Tomohiko Funai, et al.Investigational New Drugs|September 17, 2020
A phase 1 study of crenigacestat (LY3039478), the Notch inhibitor, in Japanese patients with advanced solid tumorsToshihiko Doi, Masaomi Tajimi, Joji Mori, et al.Investigational New Drugs|September 25, 2020
Switch maintenance therapy with anlotinib after chemotherapy in unresectable or metastatic soft tissue sarcoma: a single-center retrospective studyJie Liu, Yao-Tiao Deng, Yu JiangPageof 372